Hospital for Special Surgery

Hospital for Special Surgery

Hospitals and Health Care

New York, NY 86,788 followers

World #1 for Orthopedics

Über uns

HSS is a world leader in orthopedics, rheumatology and rehabilitation. At its core is Hospital for Special Surgery, the largest academic medical center specialized in musculoskeletal health founded in 1863. Ranked #1 in Orthopedics worldwide by Newsweek (3 consecutive years) and nationwide by US News & World Report (15 consecutive years). Ranked a national leader in Rheumatology and a Best Hospital for Pediatric Orthopedics by US News & World Report. HSS leadership spans patient care, research, and education. HSS maintains the lowest readmission rates for orthopedics in the nation, and among the lowest rates for infections and complications. HSS medical staff are faculty of Weill Cornell Medical College.. It is the first hospital in New York State to receive Magnet Recognition a fifth consecutive time. Patients come to HSS from all 50 States and more than 100 countries. HSS treats most patients non-surgically, but still performed more than 38,000 surgeries in 2022. HSS treats athletes from more than 100 professional sports teams from around the world, as well as the majority of all teams in Major League Baseball, National Basketball Association, the National Football League, and the National Hockey League. HSS is the Official Hospital and provides Team Physicians to more than 20 high performing teams and leagues including Major League Pickleball, the New York Giants, New York Knicks, Brooklyn Nets New York Liberty, New York Mets, New York Red Bulls, New York Road Runners, National Basketball Players Association, US Youth Soccer, and UFC. Designated a Medical Center of Excellence by Fédération Internationale de Football Association (FIFA). HSS is the only hospital in North America designated by the World Economic Forum to serve in the Global Coalition for Value in Healthcare. HSS helps Fortune 100 companies and other large employers reduce the burden of musculoskeletal conditions on their workforce.

Website
http://www.hss.edu
Industrie
Hospitals and Health Care
Größe des Unternehmens
5,001-10,000 employees
Hauptsitz
New York, NY
Typ
Nonprofit
Gegründet
1863
Spezialitäten
Orthopedics, Rheumatology, Rehabilitation, Sports Medicine, Physiatry, Neurology, Pediatric Orthopedics, Pediatric Rheumatology, Social Work, Research, and Innovation

Standorte

Employees at Hospital for Special Surgery

Aktualisierungen

  • Recently, HSS rheumatologists Jessica K. Gordon, MD, MS and Kim (Showalter) Lakin, MD, MS, attended the 2024 National Scleroderma Foundation Patient Conference in Bellevue, WA. During the conference, which provides an inclusive educational event for anyone impacted by scleroderma, Dr. Gordon gave two talks (Scleroderma 101; Gastrointestinal Issues in Systemic Sclerosis) and Dr. Lakin presented her research focused on scleroderma skin biomarker development and gave a patient lecture entitled, "The Pregnancy Journey in Scleroderma."

    • Keine alternative Textbeschreibung für dieses Bild
    • Keine alternative Textbeschreibung für dieses Bild
  • A new study published in Nature Portfolio, by researchers at HSS and others has identified a gene pathway involved in the formation of fibrous scar tissue that represents a major cause of failed joint replacements. Findings demonstrated this fibrosis can be prevented and even reversed by blocking the pathway, potentially opening the door to improved surgical outcomes in these patients. Loosening of joint implants, such as hips and knees, without infection or trauma is responsible for as many as 40 percent of failed joint replacements. In these cases, called aseptic loosening, scar tissue accumulates around the implant instead of the bone, preventing the new joint from regaining stability. “Revision surgery is akin to pressing a ‘reset button’ on the cells in the patient’s body, in the hopes that this time the cells will correctly form bone around the implant rather than fibrous tissue,” said Vincentius (Jeremy) Suhardi, MD, PhD, orthopedic surgical resident at HSS, and first author of the study. “This finding for the first time opens up the possibility of treating aseptic loosening with a drug that inhibits ADGRF5,” Dr. Suhardi said. We are planning to collaborate with strategic partners to further develop this therapy and to test its efficacy not just in aseptic loosening but also in other orthopedic-related fibrotic pathologies. https://lnkd.in/eQDiCiVs

    • Keine alternative Textbeschreibung für dieses Bild
  • Congratulations to the winners from this year’s Mets on the Move program, presented by HSS! The students who took the most steps at each participating school were honored with their physical education teachers during an on-field ceremony at Citi Field. Mets on the Move is a fitness program dedicated to keeping kids active and healthy. This year, Mets front office staff and members of our Athlete Health team worked 3,000 students across six local elementary schools throughout the month of month of May to coincide with National Physical Fitness and Sports Month. New York Mets

    • Keine alternative Textbeschreibung für dieses Bild
  • View organization page for Hospital for Special Surgery, graphic

    86,788 followers

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and immune-mediated injury to multiple organ systems. In a paper published in JAMA, HSS rheumatologists provided a current overview of the clinical manifestations of lupus, comorbidities that can affect patients, and an update on available treatment options. Hear more from rheumatologist and co-author Caroline Siegel, MD, MS. https://lnkd.in/eypicHyP

  • HSS is proud to be recognized by Becker's Healthcare as one of the great hospitals in America in 2024. These hospitals are known for top-tier clinical work, deep commitment to patient safety, innovative advancements, in-depth research, educational excellence and high levels of patient satisfaction. Leading ranking and award agencies have honored them for their industry leadership and exceptional performance across various specialties. The hospitals featured on this list are at the forefront of medical breakthroughs and discoveries, molding the future of the field. Their expertise benefits not only their own communities, but the industry as a whole. https://lnkd.in/exTShqgg

    • Keine alternative Textbeschreibung für dieses Bild
  • HSS today announced the appointment of Ashis Barad, MD, as its inaugural Chief Digital & Technology Officer (CDTO). Dr. Barad will start in the new role on September 10. Dr. Barad is a physician leader with more than 18 years of experience in clinical medicine and various technology domains, including digital and virtual health, artificial intelligence (AI), and data analytics. He comes to us from Allegheny Health Network, in Pittsburgh, where he served as Chief Digital and Information Officer. In this newly created role at HSS, Dr. Barad, who began his career as a board-certified pediatric gastroenterologist, will lead enterprise-wide technology and digital operations. He will partner with leaders throughout the organization to optimize care delivery, the patient experience, and clinical outcomes by harnessing the power of technical and digital solutions. “I’m honored to take on this new role to bridge the gap between executives, clinicians, and technical teams and drive the adoption of digital solutions into clinical workflows,” said Dr. Barad. “I look forward to collaborating with the talented HSS team to provide high-quality patient care and experience in an ever-changing digital and AI landscape.” Also on September 10, HSS Associate Chief Information Officer (CIO) Elizabeth Pearlman will succeed long-time CIO Jamie Nelson, who will assume an advisory role until her retirement in April 2025. In her new role Pearlman will report to Dr. Barad, and oversee HSS’s software development and applications, technology infrastructure, cybersecurity, and IT operations. “I’m excited to lead and continue working with colleagues who are experts in executing complex, high-profile implementations and technology deployments,” said Pearlman. “Together, we will continue to establish diverse teams to advance and modernize technical and digital capabilities at HSS." https://lnkd.in/eWAGCVtj

    • Keine alternative Textbeschreibung für dieses Bild
  • Congratulations to Andy O. Miller, MD, Chief of Infectious Diseases at HSS, on being named the new president of the Musculoskeletal Infection Society (MSIS) for 2024-2025! Founded in 1989, MSIS is a multidisciplinary educational and scientific forum for the advancement of knowledge in the field of musculoskeletal infection, for the education of patients, clinicians and researchers, and for the promotion of professional standards to guide patient care.

    • Keine alternative Textbeschreibung für dieses Bild

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen

Finanzierung